Floatz logo

Methylnaltrexone

Chronic Pain Syndrome

Florida International UniversityUNKNOWNN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

90 Active assets in the Chronic Pain Syndrome cohort.

Asset / SponsorPhaseRating
(±)-Tramadol
EMS
Phase 4BBB
Lidocaine
National and Kapodistrian University of Athens
Phase 4BBB
Methadone
Cari Health Inc.
Phase 4BBB
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Stanford University
Phase 4BBB
Nepenthe
Bursa City Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Methylnaltrexone is also rated in:

opioid-induced constipationDormant
B
Indicative · Phase 3
61 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative · Phase 3
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →